小儿动脉导管未闭介入治疗研究进展  

Treatment of the Percutaneous Closure of Patent Ducts Arteriosus in Children

作　　者：陈艳华 向平[1] 

机构地区：[1]重庆医科大学附属儿童医院心血管内科,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,儿科学重庆市重点实验室,重庆

出　　处：《临床医学进展》2022年第3期1634-1640,共7页Advances in Clinical Medicine

摘　　要：动脉导管未闭在儿童先天性心血管畸形中较为常见,随着介入技术及相关器械的迅速发展,目前经皮导管介入封堵治疗动脉导管未闭已被证实是安全有效的治疗方式。因其具有疗效好、恢复快、创伤小、并发症相对较少等优势,已逐渐成为治疗小儿动脉导管未闭的首选方案。本文总结了小儿动脉导管未闭介入治疗适应证、封堵器的选择以及术后并发症等研究进展,为临床医生提供参考。Patent ductus arteriosus is relatively common in children with congenital cardiovascular malformations. With the rapid development of interventional technology and related devices, percutaneous catheter interventional occlusion for patent ductus arteriosus has been proven to be a safe and effective treatment. Because of its advantages of good curative effect, quick recovery, less trauma, and relatively few complications, it has gradually become the first choice for the treatment of patent ductus arteriosus in children. This article summarizes the research progress in the indications of interventional therapy for pediatric patent ductus arteriosus, the selection of occluder, and postoperative complications, so as to provide reference for clinicians.

关 键 词：动脉导管未闭 介入治疗 小儿 综述 

分 类 号：R725.4[医药卫生—儿科]